investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanisms of autoinhibition and activation of the Abl kinase
Charalampos Kalodimos
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Charalampos Kalodimos
Rutgers University
New Brunswick, United States
Related projects
Kim O'Neill
Cancer Immunology Research at Brigham Young University
Leukaemia
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Pathology
Hematology and hematologic malignancies
Christopher Y Park
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia
Leukaemia
Iannis Aifantis
Genetic Dissection of Acute Myeloid Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Amy Paguirigan
Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia
Leukaemia
Ulrich G. Steidl
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
Leukaemia
David A Scheinberg
Mechanisms of action of a TCR-like antibody to WT1
Leukaemia
M. James You
CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF
Leukaemia
Hamid Band
Tyrosine Kinase Regulation Via Protein Degradation
Leukaemia
Pathology
Hematology and hematologic malignancies